First interim analysis of clinical outcomes in adults and adolescents with severe hemophilia A receiving efanesoctocog alfa prophylaxis in XTEND-ed, a phase 3 long-term extension study - Susen, S; P'ng, S; Lissitchkov, T (2024)
; Bangkok, Thailand